The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Hutchmed Ltd - Hong Kong-based developer of treatments.
EARNINGS: Hutchmed revenue surges, Craven House s loss widens lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Hutchmed Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Agrees with substantial shareholder Sinopharm Group Co Ltd to renew the Framework Sinopharm Products.
China s Junshi Nabs FDA Approval in Rare Success for US Foray bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Hutchmed Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Completes patient enrolment for bridging phase two study in China to evaluate the efficacy of cancer.